Significant Jump this Week in Reported Injuries, Deaths After COVID Vaccine

Data released today by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines showed a significant jump in reports of injuries and deaths compared with last week’s numbers.

VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Today’s data show that between Dec. 14, 2020 and April 23, a total of 118,902 total adverse events were reported to VAERS, including 3,544 deaths — an increase of 358 over the previous week — and 12,619 serious injuries, up 2,467 since last week.

In the U.S., 222.3 million COVID vaccine doses had been administered as of April 23. This includes 97 million doses of Moderna’s vaccine, 117 million doses of Pfizer and 8 million doses of the Johnson &Johnson (J&J) COVID vaccine.

Of the 3,544 deaths reported as of April 23, 25% occurred within 48 hours of vaccination, 17% occurred within 24 hours and 40% occurred in people who became ill within 48 hours of being vaccinated.

This week’s data included three reports of deaths among teens under age 18, including two 15-year-olds and one 16-year-old who died unexpectedly from a blood clot 11 days after receiving her first Pfizer dose.

A 15-year-old female died of cardiac arrest after receiving the second dose of the Moderna vaccine, and a 15-year-old male died of cardiac failure two days after receiving the Pfizer vaccine.

This week’s VAERS data show:

CDC ignores The Defender, no response after 53 days

According to the CDC website, “the CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.”

The Defender reached out to the CDC on March 8 with a written list of questions about reported deaths and injuries related to COVID vaccines, the status of ongoing investigations reported in the media, if autopsies are being done, the standard for determining whether an injury is causally connected to a vaccine, and education initiatives to encourage and facilitate proper and accurate reporting.

We made numerous attempts to contact the CDC via phone and email. As of April 30, 53 days after our initial inquiry, we still have yet to receive answers to our questions.

First ‘acknowledged’ case of J&J blood clots in a male

On April 27, The Defender reported a 30-year-old California man was hospitalized with blood clots after receiving J&J’s COVID vaccine. It is the first time U.S. public health officials have specifically acknowledged “vaccine-induced thrombotic thrombocytopenia syndrome” in a male who received J&J’s shot.

The news came days after an independent advisory panel for the CDC on April 23 voted 10 to 4 to recommend the continued use of the J&J vaccine with no restrictions after acknowledging a “possible link” between the vaccine and rare blood clotting disorders, mostly in young people. The panel concluded the benefits of the vaccine outweigh the risks.

Children’s Health Defense queried the VAERS data for a series of adverse events associated with the formation of clotting disorders and other related conditions. VAERS yielded a total of 1,845 reports for all three vaccines from Dec. 14, 2020, through April 23.

Of the 1,845 cases reported, there were 655 reports attributed to Pfizer, 577 reports to Moderna and 608 reports to J&J — an increase of 448 J&J-related cases in just one week. U.S. health officials only acknowledged 15 blood clot cases associated with the J&J vaccine at the April 16 meeting.

Children as young as 6 months in COVID vaccine trials

On April 27, ABC News reported children as young as 6 months old are now in COVID vaccine trials. Dr. Zinaida Good, research fellow and immunologist at the Stanford Medicine Cancer Center, enrolled both her sons in Stanford Hospital’s Pfizer trial. Good said she and her husband are confident in the safety of the vaccine.

“It would be wonderful if we knew how to communicate better the benefits of the vaccine and its safety. The data is very clear,” Good said. “Those who get vaccines like this, mRNA vaccines, at least they are protected and they don’t really have any real side effects, not any real long-term consequences.”

Dr. Angelica Lacour’s 3-year-old daughter, Eloise, is also participating in the trial for young children. Lacour said she was told about potential side effects. “They said that it’s incredibly rare, but anyone can have an anaphylactic reaction to it. But it’s so rare they couldn’t even give us an example,” Lacour said. “So [side effects were] not something I was very concerned about.”

It is unknown whether Pfizer informed parents of potential side effects beyond just “anaphylaxis.” According to VAERS data, 45,508 of the 118,902 total reported adverse events were attributed to Pfizer’s vaccine. Of those 45,508 adverse events, 13,116 were related to anaphylactic reactions.

Possible link between Pfizer vaccine and heart inflammation

The Defender reported April 26 on details leaked from an Israeli Health Ministry report that raised concerns among experts about a possible link between the Pfizer vaccine and myocarditis.

The preliminary report found 62 cases of myocarditis, including two deaths, in people who received the Pfizer vaccine. Fifty-six of the cases occurred after the second dose of the vaccine, and 55 cases occurred in men — most between the ages of 18 and 30.

Israel’s pandemic response coordinator, Nachman Ash, confirmed “tens of incidents” of myocarditis occurred in vaccinated people, primarily after the second dose, but emphasized the health ministry had yet to draw any conclusions.

Pfizer said it had not detected similar findings in the rest of the world but would look deeper into the phenomenon. Yet a search for “myocarditis” in VAERS revealed 75 cases of myocarditis, with 73% occurring in people between the ages of 17 and 44. Of the reported cases, 33 were reportedafter the Pfizer vaccine.

COVID vaccines and menstrual cycle disruption

Researchers this week called for clinical trials to track and document menstrual changes in vaccinated women after some women reported changes to their menstrual cycles after receiving a COVID vaccine, The Defender reported April 28.

Women have reported hemorrhagic bleeding with clots, delayed or absent periods, sudden pre-menopausal symptoms, month-long periods and heavy irregular bleeding after being vaccinated with one or both doses of a COVID vaccine.

There’s no data linking COVID vaccines to changes in menstruation because clinical trials omit tracking menstrual cycles. But two Yale University experts wrote in The New York Times last week there could be a connection.

“There are many reasons vaccination could alter menstruation,” wrote Alice Lu-Culligan, an M.D./Ph.D. student at Yale School of Medicine, and Dr. Randi Epstein, writer in residence at Yale School of Medicine.

“Periods involve the immune system, as the thickening and thinning of the uterine lining are facilitated by different teams of immune cells and signals moving in and out of the reproductive tract,” Lu-Culligan and Epstein explained. “Vaccines are designed to ignite an immune response, and the female cycle is supported by the immune system, so it’s possible vaccines could temporarily change the normal course of events.”

To find out whether the COVID vaccine truly disrupts menstrual cycles, experts say there needs to be a controlled study with a placebo group. Rather than treat menstrual cycles as unimportant or too complicated, researchers should view tracking periods in future studies as a potential opportunity, Lu-Culligan and Epstein said. Clinical trials should track and document menstrual changes as they do other possible side effects.

Government considering COVID vaccine mandate for U.S. troops

President Joe Biden said today he has not ruled out requiring all U.S. troops to get the COVID vaccine after the shots win final clearance from federal regulators, but cautioned that such a decision would be a “tough call,” Politico reported.

President Biden will not rule out ordering military to get vaccinatedhttps://t.co/dOswYqom0Q

— TODAY (@TODAYshow) April 30, 2021

The comments come as the Pentagon sounded the alarm that roughly one-third of troops and 40% of Marines had declined the vaccine as of February, according to congressional testimony from military officials.

In March, a group of Democratic lawmakers demanded Biden make the vaccine a requirement for service members, while Pentagon Press Secretary John Kirby confirmed the military’s top brass was weighing a mandatory vaccination order.

As The Defender reported this week, military officials held a virtual town hall this month in which leaders touted the vaccines and urged service members to get vaccinated, or miss out on perks granted exclusively to those who get the vaccine.

Children’s Health Defense asks anyone who has experienced an adverse reaction, to any vaccine, to file a report following these three steps.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Megan Redshaw is a freelance reporter for The Defender. She has a background in political science, a law degree and extensive training in natural health.

Featured image is from Children’s Health Defense

*** This article has been archived for your research. The original version from Global Research can be found here ***